Related Experiment Video
Updated: May 21, 2026
09:41
A Simple Critical-sized Femoral Defect Model in Mice
Published on: March 15, 2015
"Brittleness" in diabetes: easier spoken than broken
Christina Voulgari1, Stamatina Pagoni, Spyridon Paximadas
13rd Department of Internal Medicine, Athens Regional General Hospital G Gennimatas, University Medical School, Athens, Greece. c_v_24@yahoo.gr
Diabetes Technology & Therapeutics
|June 27, 2012
Summary
Brittle diabetes (BD) is an unstable condition with unpredictable glycemic fluctuations, leading to frequent complications and a compromised quality of life. Effective management requires a multidisciplinary team approach for better glycemic control and improved patient well-being.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Clinical Medicine
Background:
- Brittle diabetes (BD) is characterized by severe, unpredictable glycemic instability.
- Patients experience frequent hypoglycemia and diabetic ketoacidosis, independent of management adherence.
- This instability significantly impacts quality of life due to acute and chronic complications, leading to frequent hospitalizations.
Purpose of the Study:
- To highlight the challenges in identifying and managing brittle diabetes.
- To emphasize the need for improved diagnostic criteria and treatment strategies.
- To underscore the importance of a comprehensive, team-based approach for managing BD.
Main Methods:
- The abstract describes the clinical presentation and management difficulties of brittle diabetes.
- It emphasizes the characteristic chaotic glycemic profiles observed in BD patients.
- It discusses the inadequacy of even intensive insulin regimens in stabilizing glycemic control.
Main Results:
- Patients with BD exhibit extreme glycemic variability, exceeding that of stable diabetes patients.
- Standard intensive insulin therapies often fail to achieve adequate metabolic control.
- Care is resource-intensive and poses significant risks to patient health.
Conclusions:
- Brittle diabetes presents unique management challenges due to inherent metabolic instability.
- A multidisciplinary team approach is crucial for optimizing care and improving outcomes.
- Achieving normoglycemia and enhancing quality of life in BD patients requires coordinated, specialized interventions.
Related Concept Videos
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Stress-Strain Diagram - Brittle Materials
Brittle materials, including glass, cast iron, and stone, exhibit unique characteristics. They fracture without considerable change in their elongation rate, indicating that their breaking and ultimate strength are equivalent. Such materials also show lower strain levels at the point of rupture. The failure in brittle materials predominantly results from normal stresses, as evidenced by the rupture created along a surface perpendicular to the applied load. These materials do not display...